Buy Stocks Easy | About Us
January 20, 2021
Buy Stocks Easy | Online Stocks

MRNS


Buy Marinus Pharmaceuticals, Inc. Stock (symbol: MRNS) Easy Online

Company Name: Marinus Pharmaceuticals, Inc.

Symbol: MRNS

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

MRNS Current Share Price

Today's MRNS ( Marinus Pharmaceuticals, Inc. ) opening price: $

Yesterday's MRNS ( Marinus Pharmaceuticals, Inc. ) closing price: $

Marinus Pharmaceuticals, Inc. Stock ( symbol: MRNS ) Price Chart since IPO (2014):

12 Months Marinus Pharmaceuticals, Inc. Stock ( symbol: MRNS ) Price Chart

Popular Questions about Marinus Pharmaceuticals, Inc. Public Stock ( MRNS )

A: Marinus Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is MRNS

A: Marinus Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2014

A: Marinus Pharmaceuticals, Inc.'s stock (MRNS symbol) price at ther IPO (initial Public Offering) was $

Q: Is MRNS stock worth buying at the moment?

A: The MRNS stock performance since 2019 are rather disappointing. If you had bought 1 share of Marinus Pharmaceuticals, Inc. stock (symbol: MRNS) at the beginning of 2019, at the opening share price of $3.3200, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Marinus Pharmaceuticals, Inc. Stock Easy Online

Marinus Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Marinus Pharmaceuticals, Inc. Stock Price Yesterday



 


Marinus Pharmaceuticals, Inc. Stock Price – Last Week




 


Marinus Pharmaceuticals, Inc. Stock Price – Last Month




 


Marinus Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.zacks.com/stock/news/688615/marinus-pharmaceuticals-mrns-catches-eye-stock-jumps-77
                            

                                
Marinus Pharmaceuticals (MRNS) Catches Eye: Stock Jumps 7.7%

                                
                                
Marinus Pharmaceuticals (MRNS) shares rose nearly 8% in the last tr...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/684040/implied-volatility-surging-for-marinus-pharmaceuticals-mrns-stock-options
                            

                                
Implied Volatility Surging for Marinus Pharmaceuticals (MRNS) Stock Options

                                
                                
Investors need to pay close attention to Marinus Pharmaceuticals (M...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/13/1960601/0/en/Marinus-Pharmaceuticals-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
                            

                                
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

                                
                                
RADNOR, Pa., Dec.  13, 2019  (GLOBE NEWSWIRE) -- Marinus Pharmaceut...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/13/1960587/0/en/Marinus-Pharmaceuticals-Announces-Closing-of-70-Million-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-.html
                            

                                
Marinus Pharmaceuticals Announces Closing of $70 Million Public Offering of Common Stock and Concurrent Private Placement Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

                                
                                
RADNOR, Pa., Dec.  13, 2019  (GLOBE NEWSWIRE) -- Marinus Pharmaceut...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/12/1959789/0/en/Marinus-Pharmaceuticals-Appoints-Elan-Ezickson-to-Board-of-Directors.html
                            

                                
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

                                
                                
RADNOR, Pa., Dec.  12, 2019  (GLOBE NEWSWIRE) --  Marinus Pharmaceu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/11/1959362/0/en/Corrected-Press-Release-Marinus-Pharmaceuticals-Announces-Pricing-of-65-Million-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement.html
                            

                                
Corrected Press Release: Marinus Pharmaceuticals Announces Pricing of $65 Million Public Offering of Common Stock and Concurrent Private Placement

                                
                                
RADNOR, Pa., Dec.  11, 2019  (GLOBE NEWSWIRE) -- Marinus Pharmaceut...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/10/1958920/0/en/Marinus-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement.html
                            

                                
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

                                
                                
RADNOR, Pa., Dec.  10, 2019  (GLOBE NEWSWIRE) -- Marinus Pharmaceut...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957747/0/en/Marinus-Announces-Ganaxolone-Orphan-Epilepsy-Program-Updates-Including-Planned-Clinical-Program-in-Tuberous-Sclerosis-Complex.html
                            

                                
Marinus Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in Tuberous Sclerosis Complex

                                
                                
Initiation of Phase 2 trial evaluating ganaxolone in tuberous scler...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/07/1957516/0/en/Marinus-Presents-Additional-Data-from-Ganaxolone-Phase-2-Trial-in-Refractory-Status-Epilepticus-at-the-American-Epilepsy-Society-Annual-Meeting.html
                            

                                
Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting

                                
                                
100% of evaluable patients in target dose had no relapse during the...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.